Patent · US Expired

Method to prevent fertilization in mammals by administering a single dose of zona pellucida derived antigens, liposome and adjuvant

USRE37224E · kind E · reissue

15Cited by
7References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 23, 1998
Grant dateJun 12, 2001
Priority date
Expiry dateJul 23, 2018

Classification

  • Technology area (CPC —)General

Abstract

A vaccine for the immunocontraception of mammals is described. The vaccine consists of zona pellucida antigens and an adjuvant encapsulated in a liposome delivery system. The liposome delivery system allows for the slow release of antigen resulting in a prolonged immune response. In particular, after a single injection of the vaccine, levels of anti-zona pellucida antibodies were detected for up to 22 months in seals. Thus, the vaccine according to the present invention is effective after a single dose and is therefore very useful in immunocontraceptive protocols.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.